RESUMEN
Women with a personal history of breast cancer (PHBC) are at an increased risk of either a local recurrence or a new primary breast cancer. Thus, surveillance is essential for the detection of recurrent disease at the earliest possible stage, allowing for prompt treatment, and potentially improving overall survival. Nowadays, mammography follow-up is the only surveillance imaging technique recommended by international guidelines. Nevertheless, sensitivity of mammography is lower after breast cancer treatment, particularly during the first 5 years, due to increased density or post-treatment changes. Contrast-enhanced breast imaging techniques, such as MRI or contrast-enhanced mammography (CEM), are very sensitive to detect malignant enhancement, especially in dense breasts. This Special Report will provide arguments in favor of and against breast cancer follow-up with MRI or CEM, in a debate style between experts in Breast Imaging. Finally, the scientific points of pros and cons arguments will be summarized to help objectively decide the best follow-up strategy for women with a personal history of breast cancer. CLINICAL RELEVANCE STATEMENT: A personalized approach to follow-up imaging after conservative breast cancer treatment could optimize patient outcomes, using mammography as a baseline for most patients, and MRI or CEM selectively in patients with higher risks for a recurrence. KEY POINTS: ⢠Women with a personal history of breast cancer are at an increased risk of either a local recurrence or a new primary breast cancer. ⢠Breast cancer survivors may benefit from additional imaging with MRI/CEM, in case of increased risk of a second breast cancer, with dense breasts or a cancer diagnosis before age 50 years. ⢠As survival after local recurrence seems to depend on the initial stage at diagnosis, imaging should be more focused on detecting tumors in the earliest stages.
RESUMEN
Objetivo. Evaluar nuestra experiencia en el procedimiento de localización prequirúrgica de lesiones de mama no palpables (LMNP) y del ganglio centinela (GC) con radiotrazadores. Material y métodos. Se incluyeron las LMNP localizadas prequirúrgicamente durante el período comprendido desde enero de 2001 a diciembre de 2011. La inyección del radiotrazador se realizó guiada con ecografía o mamografía. Se obtuvo comprobación con gammagrafía prequirúrgica en todos los casos. El cirujano localizaba en quirófano las LMNP y el GC axilar con una sonda detectora portátil. El estudio histológico del GC se realizó intraoperatorio para evitar reintervenciones si estaba indicada la linfadenectomía axilar. Resultados. Se incluyeron 881 pacientes, de las cuales 226 presentaban lesiones benignas en las que estaba indicada la tumorectomía, y 655 presentaban lesiones malignas en las que estaba indicado el tratamiento quirúrgico conservador. La tasa de detección de las LMNP fue del 99,4%, consiguiendo reducir las reintervenciones por bordes afectos hasta un 7,4%. Conclusión. En nuestra experiencia la cirugía radioguiada de LMNP con radiotrazadores es una técnica sencilla y rápida que permite la extirpación con márgenes quirúrgicos suficientes y resultado estético óptimo, así como la biopsia del GC en la misma intervención ((AU)
Objective. To evaluate our experience with preoperative localization of non-palpable breast lesions (NPBL) with the injection of a radiotracer, or radioguided occult lesion localization technique, and with localization of NPBL and sentinel node (SN) with a single injection of radiotracer, or SN and occult lesion localization technique. Material and methods. We included NPBL in which excision was indicated during the period from January 2001 to December 2011. The radiotracer was injected under stereotactic or ultrasound guidance. Scintigraphy was carried out in all patients before surgery. The surgeon in the operating room had a hand-held gamma probe to locate the lesions in the breast and in the axilla. Intraoperative pathological examination of the SN was done to avoid reinterventions if there were indications for axillary lymphadenectomy. Results. We included 881 patients: 226 benign lesions were localized in patients with indications for lumpectomy and 655 malignant lesions in patients scheduled for breast conserving treatment. The detection rate of NPBL was 99.4%. Reoperations were reduced to 7.4%. Conclusion. In our experience, radioguided surgery of NPBL with radioguided occult lesion localization-SN and occult lesion localization is a quick and simple technique that allows tumor excision with adequate surgical margins and optimal cosmetic results, as well as SN biopsy during the same operation ((AU)
Asunto(s)
Humanos , Femenino , Mama/patología , Mama/cirugía , Ultrasonografía Mamaria/instrumentación , Ultrasonografía Mamaria/métodos , Ultrasonografía Mamaria , Trazadores Radiactivos , Mamografía/instrumentación , Mamografía/métodos , Mamografía , Biopsia del Ganglio Linfático Centinela/métodos , Biopsia del Ganglio Linfático Centinela/normas , Biopsia del Ganglio Linfático Centinela , Escisión del Ganglio Linfático/métodos , Escisión del Ganglio Linfático , Mamoplastia/métodosRESUMEN
El aumento en la detección de lesiones no palpables de mama ha permitido el desarrollo de métodos de localización mediante el uso de radiofármacos que nos permiten una óptima cirugía de extirpación ahorradora y, simultáneamente, la biopsia del ganglio centinela en los casos de cáncer mamario. Revisamos la bibliografía actual acerca del tema y se aprecia una eclosión de artículos sobre cirugía radioguiada en numerosos y destacados grupos de trabajo mundiales que reflejan la bondad del método, así como su eficacia y atractivo para unos cirujanos que apuestan cada vez más por la excelencia en su labor diaria. Aportamos también nuestra experiencia como grupo funcional que se extiende a 413 intervenciones sobre lesiones no palpables realizadas de forma radioguiada (ROLL) y en 229 casos de afección maligna (75%) ha sido posible simultanear con la biopsia del ganglio centinela (SNOLL). El interés que ha despertado la técnica no debe estar exento de un espíritu crítico pero innovador y reflexivo para poder analizar de forma correcta los resultados obtenidos por cada grupo, conscientes de que estamos ante métodos en que intervienen varias especialidades y cada una deberá aportar la máxima eficiencia (AU)
The increase in the detection of occult lesions has led to the development of new localisation methods using radiopharmaceutical products. The use of these products allows us to perform a thrifty (less-aggressive) surgical excision and, to simultaneously carry out the biopsy of the sentinel node in cases of breast cancer. On making a search for the most up to date references on this particular topic, we found many articles on radioguided surgery by many leading international work groups. These articles clearly show the advantages of the radioguided surgery method, its effectiveness and attractiveness to surgeons who are very much involved in the search for excellence in their daily work. We also contribute our experience as a functional group, with 413 interventions on occult lesions performed using the radioguided method (ROLL). In 229 cases out of these 413, we found a malignancy (75%); in all these 229 cases it was possible to perform the intervention simultaneously with the biopsy of the sentinel node (SNOLL), during the same surgical act. However the interest created by the new procedure, it is essential to keep a critical but innovative and reflexive mind on this issue, in order to accurately analyze the results obtained by each group. We must remember that these types of methods involve several clinical specialties and, therefore, each one will have to contribute with the highest efficiency